Gillian Cannon
About Gillian Cannon
Gillian Cannon serves as the Head of Commercial Innovation at Roivant Sciences and holds multiple advisory and board positions across various organizations, including Veritas Data Research and Newcastle University. With a strong background in the pharmaceutical industry, she has held leadership roles at Merck and UCB, and has contributed to health innovation through her work with several companies and educational institutions.
Current Role at Roivant Sciences
Gillian Cannon serves as the Head of Commercial Innovation at Roivant Sciences since 2020. In this role, she focuses on developing and implementing innovative commercial strategies to enhance the company's market presence. Roivant Sciences is known for its commitment to advancing healthcare through innovative technologies and solutions.
Board Memberships and Advisory Roles
Cannon holds several advisory and board positions. She has been a Member of the Board of Directors at Corcept Therapeutics since 2020 and at Edinburgh Innovations since the same year. Additionally, she serves as an Advisory Board Member at Veritas Data Research since 2023 and is a Member of the Advisory Circle at Newcastle University since 2021. These roles allow her to influence strategic decisions in various organizations.
Professional Experience in Pharmaceutical Industry
Cannon has extensive experience in the pharmaceutical industry, having held various senior roles at Merck, including Global Vice President of Commercial Operations and Senior Director of Sales. She also served as President of North American Operations at UCB and as Senior Vice President at Otsuka America Pharmaceutical, Inc. Her career includes significant contributions to commercial strategy and operations within leading pharmaceutical companies.
Educational Background
Cannon studied Biochemistry at The University of Edinburgh, where she earned a Bachelor of Science degree. She furthered her education at Temple University, obtaining a PhD in Health Services Administration. Her academic background supports her extensive career in the pharmaceutical and healthcare sectors.
Contributions to Health Innovation
Cannon co-founded Castle Biotech LLC, focusing on developing innovative biotechnological solutions. She also actively contributes to the strategic direction of Our Future Health Trading Limited, emphasizing health innovation. Her involvement in these initiatives reflects her commitment to advancing healthcare through innovative approaches.